Biotech News
Intellia Therapeutics Announces Proposed Public Offering of Common Stock
ir.intelliatx.com2026-04-27 20:12 EST
CAMBRIDGE, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced that it has commenced an underwritten public offering